Abstract:AIM: To construct a stable transfectant of human liver carcinoma cell line SMMC7721 that could secret human endostatin and to explore the effect of human endostatin expressed by the transfectant on endothelial cell proliferation.METHODS: Recombinant retroviral plasmid pLncx-Endo containing the cDNA for human endostain gene together with rat albumin signal peptide was engineered and transferred into SMMC7721 cell by lipofectamine. After selection with G418, endostatin-transfected SMMC7721 cells were chosen and expanded. Immunohistochemical staining and Western blot were used to detect the expression of human endostatin in transfected SMMC7721 cells and its medium, The conditioned medium of endostidin-transfected and control SMMC7721 cells were collected to cultivate with human umbilical vein endothelial cells for 72 hours. The inhibitory effect of endostatin, expressed by transfected SMMC7721 cells, on endothelial proliferation in vitro was observed by using MTT assay.RESULTS: A 550 bp specific fragment of endostatin gene was detected from the PCR product of endostatin-transfected SMMC7721 cells. Immunohistochemistry and Western blot analysis confirmed the expression and secretion of foreigh human endostatin protein by endostatin-transfected SMMC7721 cells. In vitro endothelial proliferation assay showed that 72 hours after cultivation with human umbilical vein endothelial cells, the optical density (OD) In group using the medium from endostatin-transfected SMMC7721 cells was 0.51 +/- 0.06, lower than that from RPMI 1640 group (0.98 +/- 0.09) or that from control plasmid pLncx-transfected SMMG7721 cells (0.88 +/- 0.11). The inhibitory rate for medium from endostatin-transfected SMMC7721 cells was 48%, significantly higher than that from empty plasmid pLncx-transfected SMMC7721 calls (10.2%, P < 0.01).CONCLUSION: Human endostatin can be stably expressed by SMMC7721 cell transferred with human endostain gene and its product can significantly inhibit the proliferation of human umbilical vein endothelial cell in vitro.

STUDY OF ANTI-TUMOR EFFECT OF RECOMBINANT HUMAN ENDOSTATIN

Therapeutic Efficacy of Recombinant Human Endostatin Combined with Chemotherapeutics in Mice-Transplanted Tumors

An Experimental Research into Endostatin Microbubble Combined with Focused Ultrasound for Anti-Tumor Angiogenesis in Colon Cancer

Anti-Tumor Effect Of Human Endostatin Mediated By Retroviral Gene Transfer In Nude Mice

Research of the Anti-Tumor Effect of Human Endostatin Mediated by Recombinant Adeno-Associated Virus

Construction of pcDNA3-Endo eukaryon expression plasmid and angiogenesis inhibition in vitro

Retrovirus-mediated Gene Transfer of Human Endostatin Inhibits Growth of Human Liver Carcinoma Cells SMMC7721 in Nude Mice

Discrepancies between antiangiogenic and antitumor effects of recombinant human endostatin.

Effect of recombinant human endostatin on microenvironment of human lung adenocarcinoma

Bioactivity, Pharmacokinetics, and Immunogenicity Assays in Preclinical and Clinical Trials for Recombinant Human Endostatin

[Biological Effect of Endostatin on Transplanted Human Lung Adenocarcinoma Calu-6 Tumor in Nude Mice].

Inhibitory Effect of Endostatin Expressed by Human Liver Carcinoma SMMC7721 on Endothelial Cell Proliferation in Vitro.

Inhibitory effect of endostatin mediated by retroviral gene transfer on human liver carcinoma SMMC 7721 in vivo

Effects of recombinant human endostatin and its synergy with cisplatin on circulating endothelial cells and tumor vascular normalization in A549 xenograft murine model

Anti-tumor Effect Through Human Endostatin Gene Transfer in Nude Mice-Bearing Human Colorectal Cancer

Inhibitory Effect of Adeno-Associated Virus-Mediated Gene Transfer of Human Endostatin on Hepatocellular Carcinoma

[Anti-Tumor Effect Through Human Endostatin Gene Transfer in Mice Bearing B16 Melanoma].

Anticancer Treatment of Endostatin Gene Therapy by Targeting Tumor Neovasculature in C57/BL Mice.

Inhibitory effects of endostatin on rats sarcoma xenografts in different growth stages

[Preliminary Study on the Anti-Leukemia Effect of Recombinant Human Endostatin].

Recombinant human endostatin as a potential anti-angiogenic agent: therapeutic perspective and current status